DE69027666D1 - Herstellung von biologischaktivem insulinähnlichem wachstumsfaktor i aus hochexpressions-wirtszellsystemen - Google Patents

Herstellung von biologischaktivem insulinähnlichem wachstumsfaktor i aus hochexpressions-wirtszellsystemen

Info

Publication number
DE69027666D1
DE69027666D1 DE69027666T DE69027666T DE69027666D1 DE 69027666 D1 DE69027666 D1 DE 69027666D1 DE 69027666 T DE69027666 T DE 69027666T DE 69027666 T DE69027666 T DE 69027666T DE 69027666 D1 DE69027666 D1 DE 69027666D1
Authority
DE
Germany
Prior art keywords
igf
production
host cell
growth factor
biologically active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69027666T
Other languages
English (en)
Other versions
DE69027666T2 (de
Inventor
James Miller
Philip Hsieh
Larry Tsai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Inc
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of DE69027666D1 publication Critical patent/DE69027666D1/de
Publication of DE69027666T2 publication Critical patent/DE69027666T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69027666T 1989-08-25 1990-08-21 Herstellung von biologischaktivem insulinähnlichem wachstumsfaktor i aus hochexpressions-wirtszellsystemen Expired - Fee Related DE69027666T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/398,699 US5158875A (en) 1989-08-25 1989-08-25 Production of biologically active insulin-like growth factor i from high expression host cell systems
PCT/US1990/004739 WO1991002807A1 (en) 1989-08-25 1990-08-21 Production of biologically active insulin-like growth factor i from high expression host cell systems

Publications (2)

Publication Number Publication Date
DE69027666D1 true DE69027666D1 (de) 1996-08-08
DE69027666T2 DE69027666T2 (de) 1996-11-07

Family

ID=23576440

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69027666T Expired - Fee Related DE69027666T2 (de) 1989-08-25 1990-08-21 Herstellung von biologischaktivem insulinähnlichem wachstumsfaktor i aus hochexpressions-wirtszellsystemen

Country Status (10)

Country Link
US (1) US5158875A (de)
EP (1) EP0441955B1 (de)
JP (1) JPH04501514A (de)
AT (1) ATE140029T1 (de)
AU (1) AU644105B2 (de)
CA (1) CA2023969A1 (de)
DE (1) DE69027666T2 (de)
DK (1) DK0441955T3 (de)
ES (1) ES2089029T3 (de)
WO (1) WO1991002807A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316932A (en) * 1989-03-24 1994-05-31 Duke University Homogeneous denatured human 06-guanine alkyltransferase prepared by immunoaffinity chromatography using monoclonal antibody specific for enzyme
WO1992003477A1 (en) * 1990-08-20 1992-03-05 Novo Nordisk A/S Biologically active compound, a process for the preparation thereof and use of the same
US5646016A (en) * 1991-02-06 1997-07-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
US5378613A (en) * 1991-09-24 1995-01-03 Eli Lilly And Company Method for increased expression of low molecular weight recombinant polypeptides
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5958764A (en) * 1992-04-30 1999-09-28 Baylor College Of Medicine Specific expression vectors and methods of use
DE69403654T2 (de) * 1993-03-29 1997-12-11 Du Pont Ein verfahren zur erhöhung der produktion von biologisch aktiven rekombinanten proteinen
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
US5407810A (en) * 1993-08-20 1995-04-18 Genentech, Inc. Aqueous multiple-phase isolation of polypeptide
SE9303784D0 (sv) * 1993-11-16 1993-11-16 Kabi Pharmacia Ab Igf
US5451660A (en) * 1993-12-13 1995-09-19 Genentech, Inc. Method for purifying polypeptides
AU1272295A (en) * 1993-12-17 1995-07-03 Novo Nordisk A/S Proinsulin-like compounds
US5712249A (en) * 1994-09-08 1998-01-27 Ciba-Geigy Corporation Use of insulin-like growth factors I and II for inhibition of inflammatory response
EP0779927A1 (de) * 1994-09-08 1997-06-25 Chiron Corporation Methode zur gesteigerten herstellung von insulin-ähnlichem wachstumsfaktor
US5789547A (en) * 1995-06-07 1998-08-04 Celtrix Pharmaceuticals, Inc. Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding
SG121902A1 (en) * 2000-01-11 2006-05-26 Maxygen Inc Integrated systems for diversity generation and screening
WO2008005533A2 (en) * 2006-07-06 2008-01-10 Aaron Thomas Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
CL2007002502A1 (es) * 2006-08-31 2008-05-30 Hoffmann La Roche Variantes del factor de crecimiento similar a insulina-1 humano (igf-1) pegilados en lisina; metodo de produccion; proteina de fusion que la comprende; y su uso para tratar la enfermedad de alzheimer.
AU2007291501B2 (en) * 2006-08-31 2012-07-12 F. Hoffmann-La Roche Ag Method for the production of insulin-like growth factor-I
ES2388827T3 (es) * 2008-04-03 2012-10-19 F. Hoffmann-La Roche Ag Uso de variantes de IGF-I PEGiladas para el tratamiento de trastornos neuromusculares
MX2010010313A (es) * 2008-04-03 2010-11-05 Hoffmann La Roche Analisis de factor de crecimiento pegilado similar a insulina.
BR112012000865A2 (pt) 2009-07-17 2019-09-24 T Tabor Aaron "composição e método para a modificação genética cosmética de células substancialmente intactas"
US20110152188A1 (en) * 2009-12-23 2011-06-23 Hanns-Christian Mahler Pharmaceutical compositions of igf/i proteins
US9675671B2 (en) * 2014-01-12 2017-06-13 Igf Oncology, Llc Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants thereof and uses thereof
CN112892220B (zh) * 2021-01-19 2023-02-17 南开大学 一种高效的活性蛋白分离方法与装置
CN114292800A (zh) * 2021-12-27 2022-04-08 普健生物（武汉）科技有限公司 用于igf-1基因重组表达的重组细胞和重组表达方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4532207A (en) * 1982-03-19 1985-07-30 G. D. Searle & Co. Process for the preparation of polypeptides utilizing a charged amino acid polymer and exopeptidase
FR2594846B1 (fr) * 1986-02-21 1989-10-20 Genetica Procede de preparation de la serum albumine humaine mature
EP0371041A1 (de) * 1987-06-24 1990-06-06 Novo Nordisk A/S Verfahren für die herstellung eines proteins oder polypeptides, dns-sequenz, die dieses polypeptid kodiert, mikroorganismus, der diese dns-sequenz beinhaltet, sowie das polypeptid und seine verwendung als pharmazeutisches präparat

Also Published As

Publication number Publication date
US5158875A (en) 1992-10-27
AU644105B2 (en) 1993-12-02
DE69027666T2 (de) 1996-11-07
AU6425490A (en) 1991-04-03
EP0441955B1 (de) 1996-07-03
DK0441955T3 (da) 1996-10-07
CA2023969A1 (en) 1991-02-26
EP0441955A1 (de) 1991-08-21
EP0441955A4 (en) 1992-07-15
JPH04501514A (ja) 1992-03-19
WO1991002807A1 (en) 1991-03-07
ES2089029T3 (es) 1996-10-01
ATE140029T1 (de) 1996-07-15

Similar Documents

Publication Publication Date Title
DE69027666D1 (de) Herstellung von biologischaktivem insulinähnlichem wachstumsfaktor i aus hochexpressions-wirtszellsystemen
CA2168429A1 (en) Expression of fusion polypeptides transported out of cytoplasm without leader sequences
EP1293513A3 (de) Rekombinanter Abkömmling des menschlichen Faktors VIII
PT714406E (pt) Re-enrolamento de polipeptidos tais como o factor de crescimento semelhante a insulina igf-i recombinante
CA2089094A1 (en) Expression of recombinant polypeptides with improved purification
ATE123949T1 (de) B-ketten-analoge des von blutplättchen abstammenden wachstumsfaktors und verfahren zu deren homogener herstellung.
PT955313E (pt) Nova proteina e processo para a sua producao
DE59611434D1 (de) Herstellung von Proteinen aus Pro-Proteinen durch Fusionsproteine abgeleitet von Furin oder Furinanalogen
ES2104635T3 (es) Nuevo peptido porcino con una actividad fisiologica (cnp-53).
DE69126487D1 (de) cDNA für Ratten C-Typ natriuretisches Peptid und Vorläuferprotein
ATE108458T1 (de) Immunglobulin-e-kompetitor.
KR930013115A (ko) Dna 분자 및 숙주
ES2091237T3 (es) Nuevo procedimiento para la produccion de proteina no fusionada en e. coli.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
ATE141645T1 (de) In vitro-behandlung von fusionsproteinen
KR880701073A (ko) 제조합 dna 기법에 의해 생성된 민악티빈
DE59109235D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
ATE315646T1 (de) Leukocyten-aktivierender faktor
KR890013177A (ko) 신규폴리펩티드 및 그것을 코우드하는 dna
RU92016315A (ru) Вектор, плазмида, способ получения протеина и метаболита, бактерия, применение бактерии

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee